More information will be provided when confirmed
Program
| DAY THREE: 23 FEBRUARY 2011 (Wednesday) | |||
| Time | Duration (mins) | Title | Speaker |
| Session 5 - Targeted Therapeutics | |||
| 9:00 | 25 | Challenges In Oncology Drug Development | Richard GAYNOR |
| 9:25 | 15 | Discussion | |
| 9:40 | 25 | Clinical experience with targeted therapeutics and study design challenges | Elizabeth EISENHAUER |
| 10:05 | 15 | Discussion | |
| 10:20 | 30 | COFFEE BREAK | |
| 10:50 | 25 | Adrenoceptors: a model for translational research – paving the way for personalized medicine | Desmond POWE |
| 11:15 | 15 | Discussion | |
| 11:30 | 25 | Epigenetic Regulation of Targeted Therapy | Qiang YU |
| 11:55 | 15 | Discussion | |
| 12:10 | 60 | LUNCH | |
| 13:10 | 25 | Pharmocogenomic biomarker in cancer treatment | Sun Young RHA |
| 13:35 | 15 | Discussion | |
| 13:50 | 20 | Concluding remarks | Kurt ZAENKER |
| 14:10 | END OF CONFERENCE | ||